id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-2604-0006,FDA,FDA-2015-E-2604,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ZYDELIG—New Drug Application 205858",Notice,Determinations,2018-02-15T05:00:00Z,2018,2,2018-02-15T05:00:00Z,2018-04-17T03:59:59Z,2024-02-20T16:20:23Z,2018-03134,0,0,0900006482f35836